4.6 Article

Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia

期刊

BLOOD ADVANCES
卷 3, 期 17, 页码 2598-2603

出版社

AMER SOC HEMATOLOGY
DOI: 10.1182/bloodadvances.2018021295

关键词

-

资金

  1. National Institutes of Health, National Cancer Institute [P01 CA171983, K22 CA190674]
  2. Memorial Sloan Kettering Cancer Center Support Grant/Core Grant [P30 CA0087480]
  3. National Institute of General Medical Sciences, University of New Hampshire COBRE Pilot Project [P20 GM113131]
  4. Bess Family Charitable Fund
  5. Penn State University Kiesendahl Family Endowed Leukemia Research Fund
  6. Kenneth Noel Memorial Fund
  7. Pennsylvania Tobacco Settlement funds

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据